Skip to Content
Merck
  • Enantioselective analysis of glufosinate using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate and reversed-phase liquid chromatography.

Enantioselective analysis of glufosinate using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate and reversed-phase liquid chromatography.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2002-07-26)
Yasushi Hori, Manami Fujisawa, Kenji Shimada, Mitsuru Sato, Masao Honda, Yasuo Hirose
ABSTRACT

We have developed a new analytical method to quantify the DL-homoalanine-4-yl(methyl)phosphinate (DL-GLUF) enantiomers in biological specimens using a reversed-phase high-performance liquid chromatography system with a fluorescence detection system. The derivatization of DL-GLUF enantiomers with (+)-1-(9-fluorenyl)ethyl chloroformate was carried out under mild conditions (40 degrees C for 30 min) without inducing racemization. The lower limit of quantitation was 0.01 microg/ml for both D-GLUF and L-GLUF, and the detection limit was 5 ng/ml. When DL-GLUF enantiomers were added to serum to produce concentrations between 0.1 and 100 microg/ml, the mean recovery rate was at least 93.8%. The recovery rate from urine was also satisfactory.

MATERIALS
Product Number
Brand
Product Description

Supelco
(+)-1-(9-Fluorenyl)ethyl chloroformate solution, ≥18 mM in acetone, for chiral derivatization, LiChropur
Sigma-Aldrich
(+)-1-(9-Fluorenyl)ethyl chloroformate solution, 18 mM in acetone, for chiral derivatization